
Carenostics is a healthcare AI company focused on addressing the underdiagnosis and undertreatment of chronic diseases. By integrating with provider EHR data, Carenostics identifies high-risk, undiagnosed chronic disease patients and activates clinicians for earlier intervention. Their flagship solution, CKDx, is designed to eradicate undiagnosed chronic kidney disease and reduce healthcare disparities, particularly among minority populations. With over 300 health system deployments nationwide and a strong emphasis on clinical accuracy and innovation, Carenostics is positioned as a leader in the healthcare AI space, backed by a team with extensive experience and a commitment to improving patient outcomes.

Carenostics is a healthcare AI company focused on addressing the underdiagnosis and undertreatment of chronic diseases. By integrating with provider EHR data, Carenostics identifies high-risk, undiagnosed chronic disease patients and activates clinicians for earlier intervention. Their flagship solution, CKDx, is designed to eradicate undiagnosed chronic kidney disease and reduce healthcare disparities, particularly among minority populations. With over 300 health system deployments nationwide and a strong emphasis on clinical accuracy and innovation, Carenostics is positioned as a leader in the healthcare AI space, backed by a team with extensive experience and a commitment to improving patient outcomes.
What they do: Healthcare AI that identifies undiagnosed and high-risk chronic disease patients from EHR data
Flagship product: CKDx — focused on eradicating undiagnosed chronic kidney disease
Scale: Deployed in over 300 health systems (stated)
Funding: Seed round closed Sep 13–14, 2023; reported $5M total funding
Headquarters & founding: Berwyn, Pennsylvania; founded circa 2021
Founder / CEO: Bharat Rao
Underdiagnosis and undertreatment of chronic diseases; healthcare disparities in chronic disease outcomes.
2021
Healthcare / Healthtech / Artificial Intelligence
5000000.00 USD
Seed round announced Sep 13–14, 2023; investors listed include M13, Kurt Hilzinger, GreatPoint Ventures, Gaingels.
“Lead investor M13; additional investors include Kurt Hilzinger, GreatPoint Ventures, Gaingels”